FibroGen Stock Forecast

Sell candidate since Feb 25, 2025 Loss -26.16%

The FibroGen stock price gained 17.14% on the last trading day (Monday, 24th Mar 2025), rising from $0.315 to $0.369. During the last trading day the stock fluctuated 16.86% from a day low at $0.325 to a day high of $0.380. The price has risen in 6 of the last 10 days but is still down by -3.15% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 412 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $1.01 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.311 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -23.91% during the next 3 months and, with a 90% probability hold a price between $0.237 and $0.525 at the end of this 3-month period.

FGEN Signals & Forecast

There are mixed signals in the stock today. The FibroGen stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.373 and $0.461. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Friday, March 21, 2025, and so far it has risen 17.14%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). FibroGen has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for FibroGen stock

FibroGen finds support from accumulated volume at $0.360 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0548 between high and low, or 16.86%. For the last week, the stock has had daily average volatility of 14.58%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FGEN) For The Upcoming Trading Day Of Tuesday 25th

For the upcoming trading day on Tuesday, 25th we expect FibroGen to open at $0.358, and during the day (based on 14 day Average True Range), to move between $0.306 and $0.432, which gives a possible trading interval of +/-$0.0632 (+/-17.13%) up or down from last closing price. If FibroGen takes out the full calculated possible swing range there will be an estimated 34.27% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.360 (2.33%) than the resistance at $0.381 (3.25%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is FibroGen stock A Buy?

FibroGen holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.704 Sell Candidate Upgraded

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on March 25, 2025 - $0.358 ( 3.00%).